Inability of a Mouse Cell Line Transformed to Produce Biologically Active Recombinant Human Insulin-Like Growth Factor I (IGF-I) to Respond to Exogenously Added IGF-I
Year: 1988
Type: article
Source: Endocrinology
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2086420490
